🇺🇸 FDA
Patent

US 10092598

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

granted A61KA61K2300/00A61K2800/87

Quick answer

US patent 10092598 (Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo) held by RegenLab USA LLC expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RegenLab USA LLC
Grant date
Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2300/00, A61K2800/87, A61K35/14, A61K35/15